129 related articles for article (PubMed ID: 35019261)
1. Zwitterion-Coated Ultrasmall MnO Nanoparticles Enable Highly Sensitive
Wei R; Liu K; Zhang K; Fan Y; Lin H; Gao J
ACS Appl Mater Interfaces; 2022 Jan; 14(3):3784-3791. PubMed ID: 35019261
[TBL] [Abstract][Full Text] [Related]
2. One-pot preparation of hydrophilic manganese oxide nanoparticles as T
Li J; Wu C; Hou P; Zhang M; Xu K
Biosens Bioelectron; 2018 Apr; 102():1-8. PubMed ID: 29101783
[TBL] [Abstract][Full Text] [Related]
3. Improving the sensitivity of
Yang L; Wang L; Huang G; Zhang X; Chen L; Li A; Gao J; Zhou Z; Su L; Yang H; Song J
Theranostics; 2021; 11(14):6966-6982. PubMed ID: 34093865
[No Abstract] [Full Text] [Related]
4. Mesoporous manganese silicate coated silica nanoparticles as multi-stimuli-responsive T1-MRI contrast agents and drug delivery carriers.
Li X; Zhao W; Liu X; Chen K; Zhu S; Shi P; Chen Y; Shi J
Acta Biomater; 2016 Jan; 30():378-387. PubMed ID: 26602820
[TBL] [Abstract][Full Text] [Related]
5. Fabrication and evaluation of tumor-targeted positive MRI contrast agent based on ultrasmall MnO nanoparticles.
Huang H; Yue T; Xu K; Golzarian J; Yu J; Huang J
Colloids Surf B Biointerfaces; 2015 Jul; 131():148-54. PubMed ID: 25982318
[TBL] [Abstract][Full Text] [Related]
6. Synthesis Of PEG-Coated, Ultrasmall, Manganese-Doped Iron Oxide Nanoparticles With High Relaxivity For T
Xiao S; Yu X; Zhang L; Zhang Y; Fan W; Sun T; Zhou C; Liu Y; Liu Y; Gong M; Zhang D
Int J Nanomedicine; 2019; 14():8499-8507. PubMed ID: 31695377
[TBL] [Abstract][Full Text] [Related]
7. Folic acid-conjugated MnO nanoparticles as a T1 contrast agent for magnetic resonance imaging of tiny brain gliomas.
Chen N; Shao C; Qu Y; Li S; Gu W; Zheng T; Ye L; Yu C
ACS Appl Mater Interfaces; 2014 Nov; 6(22):19850-7. PubMed ID: 25335117
[TBL] [Abstract][Full Text] [Related]
8. Water-soluble MnO nanocolloid for a molecular T1 MR imaging: a facile one-pot synthesis, in vivo T1 MR images, and account for relaxivities.
Baek MJ; Park JY; Xu W; Kattel K; Kim HG; Lee EJ; Patel AK; Lee JJ; Chang Y; Kim TJ; Bae JE; Chae KS; Lee GH
ACS Appl Mater Interfaces; 2010 Oct; 2(10):2949-55. PubMed ID: 20929249
[TBL] [Abstract][Full Text] [Related]
9. In Vivo Dual-Modality Fluorescence and Magnetic Resonance Imaging-Guided Lymph Node Mapping with Good Biocompatibility Manganese Oxide Nanoparticles.
Zhan Y; Zhan W; Li H; Xu X; Cao X; Zhu S; Liang J; Chen X
Molecules; 2017 Dec; 22(12):. PubMed ID: 29231865
[TBL] [Abstract][Full Text] [Related]
10. Bifunctional Pyrrolidin-2-one Terminated Manganese Oxide Nanoparticles for Combined Magnetic Resonance and Fluorescence Imaging.
Banerjee A; Bertolesi GE; Ling CC; Blasiak B; Purchase A; Calderon O; Tomanek B; Trudel S
ACS Appl Mater Interfaces; 2019 Apr; 11(14):13069-13078. PubMed ID: 30883086
[TBL] [Abstract][Full Text] [Related]
11. Tuning the size and composition of manganese oxide nanoparticles through varying temperature ramp and aging time.
Martinez de la Torre C; Grossman JH; Bobko AA; Bennewitz MF
PLoS One; 2020; 15(9):e0239034. PubMed ID: 32946514
[TBL] [Abstract][Full Text] [Related]
12. Manganese Oxide Nanoparticles As MRI Contrast Agents In Tumor Multimodal Imaging And Therapy.
Cai X; Zhu Q; Zeng Y; Zeng Q; Chen X; Zhan Y
Int J Nanomedicine; 2019; 14():8321-8344. PubMed ID: 31695370
[TBL] [Abstract][Full Text] [Related]
13. L-DOPA-Coated Manganese Oxide Nanoparticles as Dual MRI Contrast Agents and Drug-Delivery Vehicles.
McDonagh BH; Singh G; Hak S; Bandyopadhyay S; Augestad IL; Peddis D; Sandvig I; Sandvig A; Glomm WR
Small; 2016 Jan; 12(3):301-6. PubMed ID: 26619158
[TBL] [Abstract][Full Text] [Related]
14. Water-soluble and biocompatible MnO@PVP nanoparticles for MR imaging in vitro and in vivo.
Hu X; Ji Y; Wang M; Miao F; Ma H; Shen H; Jia N
J Biomed Nanotechnol; 2013 Jun; 9(6):976-84. PubMed ID: 23858961
[TBL] [Abstract][Full Text] [Related]
15. MnO nanoparticles with unique excitation-dependent fluorescence for multicolor cellular imaging and MR imaging of brain glioma.
Lai J; Wang T; Wang H; Shi F; Gu W; Ye L
Mikrochim Acta; 2018 Apr; 185(4):244. PubMed ID: 29610993
[TBL] [Abstract][Full Text] [Related]
16. MnO nanoparticles with potential application in magnetic resonance imaging and drug delivery for myocardial infarction.
Zheng Y; Zhang H; Hu Y; Bai L; Xue J
Int J Nanomedicine; 2018; 13():6177-6188. PubMed ID: 30323598
[TBL] [Abstract][Full Text] [Related]
17. Cy5.5 conjugated MnO nanoparticles for magnetic resonance/near-infrared fluorescence dual-modal imaging of brain gliomas.
Chen N; Shao C; Li S; Wang Z; Qu Y; Gu W; Yu C; Ye L
J Colloid Interface Sci; 2015 Nov; 457():27-34. PubMed ID: 26151564
[TBL] [Abstract][Full Text] [Related]
18. MnO-labeled cells: positive contrast enhancement in MRI.
Létourneau M; Tremblay M; Faucher L; Rojas D; Chevallier P; Gossuin Y; Lagueux J; Fortin MA
J Phys Chem B; 2012 Nov; 116(44):13228-38. PubMed ID: 23030472
[TBL] [Abstract][Full Text] [Related]
19. Composition-Tunable Ultrasmall Manganese Ferrite Nanoparticles: Insights into their
Miao Y; Xie Q; Zhang H; Cai J; Liu X; Jiao J; Hu S; Ghosal A; Yang Y; Fan H
Theranostics; 2019; 9(6):1764-1776. PubMed ID: 31037137
[TBL] [Abstract][Full Text] [Related]
20. Paramagnetic nanoparticle T1 and T2 MRI contrast agents.
Xu W; Kattel K; Park JY; Chang Y; Kim TJ; Lee GH
Phys Chem Chem Phys; 2012 Oct; 14(37):12687-700. PubMed ID: 22885983
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]